At Mylan, our mission is to provide the world’s 7 billion people access to high quality medicine. We have nearly 15,000 dedicated individuals working in India who are critical to helping the company deliver on this promise.  

Mylan’s businesses in India are helping fulfill the unmet medical needs of not only Indian patients through our domestic business, but also patients around the world through our third-party active pharmaceutical ingredient (API), antiretrovirals (ARV) and emerging markets businesses.


ARVs and Emerging Markets

Through our operations in India, Mylan has earned a reputation for being one of the world’s leading suppliers of high quality, affordable ARV medicines to treat HIV/AIDS. In fact, 50% of our API manufacturing capacity is dedicated to ARVs, which we sell in more than 100 countries. More than 40% of the nearly 21 million HIV+ patients being treated today – and 60% of the world’s HIV+ children – depend on one of our products. We export our ARV products as well as many other medicines that we manufacture in India, including tablets, capsules and injectables, to emerging markets around the world, such as Africa, Latin America, the Middle East, North Africa and South East Asia.

India Domestic Business

In 2012, Mylan launched its domestic business in India with a comprehensive ARV portfolio. Since then, the company has expanded its sales force in India to include more than 400 representatives and launched Critical Care, Hepato Care, HIV Care, Oncology Care and Women’s Health Care segments. In addition to providing a broad range of products, Mylan has launched several educational initiatives in India to support medical professionals in their efforts to more effectively treat their patients and help patients better manage their disease.

Third-party API

Mylan is one of the world’s largest API manufacturers, all of which are made in India. A number of third parties rely on Mylan’s supply of high quality, affordable API to develop their own products. We offer customers a broad portfolio of more than 250 APIs in a wide range of categories, including antiasthmatics, antibacterials, antidiabetics, antifungals, antihistamines, antivirals, cardiovascular therapies, central nervous system agents, proton pump inhibitors and pain management drugs.

We also offer API customers in more than 100 countries integrated services, including:

    • Early development, 

    • intellectual property support,
    • drug master file submissions,
    • query responses and
    • commercial supplies for launch.

  • Questions?

    Get more information on our products, services and Mylan Global Center locations.
    Contact Us
  • Business Opportunities

    Do you have an opportunity or a collaboration idea?
    Partner with us